Global Microrna (mirna) Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	166 Pages	TechNavio	August, 2024	INF19287809

Best Price Guarantee
Price	from $2,500
Length	166 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19287809

Microrna (MIRNA) Market 2024-2028

The microrna (MIRNA) market is forecasted to grow by USD 3186.2 mn during 2023-2028, accelerating at a CAGR of 23.31% during the forecast period. The report on the microrna (MIRNA) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, increasing research activities in pharmaceutical and biotechnology sectors, and significant scientific progress in miRNA approach.

Technavio's microrna (MIRNA) market is segmented as below:

By Type
Consumables
Instruments
By End-user
Academic and government research institutes
Biotechnology and pharmaceutical companies
CROs and clinical diagnostic centers
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of partnerships and collaborations of market vendors as one of the prime reasons driving the microrna (MIRNA) market growth during the next few years. Also, rapid growth potential in developing economies and growing adoption of artificial intelligence for disease evaluation will lead to sizable demand in the market.

The report on the microrna (MIRNA) market covers the following areas:

Microrna (MIRNA) market sizing
Microrna (MIRNA) market forecast
Microrna (MIRNA) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microrna (MIRNA) market vendors that include BioGenex Laboratories Inc., BioVendor Laboratorni medicina AS, GeneCopoeia Inc., Genelinx International Inc., HEIM BIOTEK, Illumina Inc., InteRNA Technologies B.V., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, NanoString Technologies Inc., New England Biolabs Inc., OriGene Technologies Inc., Perkin Elmer Inc., QIAGEN NV, Quantabio, Regulus Therapeutics Inc., SeqMatic LLC, Takara Bio Inc., TAmiRNA GmbH, and Thermo Fisher Scientific Inc.. Also, the microrna (MIRNA) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global MicroRNA (MiRNA) Market 2018 - 2022; Historic Market Size - Data Table on Global MicroRNA (MiRNA) Market 2018 - 2022 ($ million); 4.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.3 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 6.3 Consumables - Market size and forecast 2023-2028; Chart on Consumables - Market size and forecast 2023-2028 ($ million); Data Table on Consumables - Market size and forecast 2023-2028 ($ million); Chart on Consumables - Year-over-year growth 2023-2028 (%); Data Table on Consumables - Year-over-year growth 2023-2028 (%); 6.4 Instruments - Market size and forecast 2023-2028; Chart on Instruments - Market size and forecast 2023-2028 ($ million); Data Table on Instruments - Market size and forecast 2023-2028 ($ million); Chart on Instruments - Year-over-year growth 2023-2028 (%); Data Table on Instruments - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 7.3 Academic and government research institutes - Market size and forecast 2023-2028; Chart on Academic and government research institutes - Market size and forecast 2023-2028 ($ million); Data Table on Academic and government research institutes - Market size and forecast 2023-2028 ($ million); Chart on Academic and government research institutes - Year-over-year growth 2023-2028 (%); Data Table on Academic and government research institutes - Year-over-year growth 2023-2028 (%); 7.4 Biotechnology and pharmaceutical companies - Market size and forecast 2023-2028; Chart on Biotechnology and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Data Table on Biotechnology and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Chart on Biotechnology and pharmaceutical companies - Year-over-year growth 2023-2028 (%); Data Table on Biotechnology and pharmaceutical companies - Year-over-year growth 2023-2028 (%); 7.5 CROs and clinical diagnostic centers - Market size and forecast 2023-2028; Chart on CROs and clinical diagnostic centers - Market size and forecast 2023-2028 ($ million); Data Table on CROs and clinical diagnostic centers - Market size and forecast 2023-2028 ($ million); Chart on CROs and clinical diagnostic centers - Year-over-year growth 2023-2028 (%); Data Table on CROs and clinical diagnostic centers - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 BioVendor Laboratorni medicina AS; BioVendor Laboratorni medicina AS - Overview; BioVendor Laboratorni medicina AS - Product / Service; BioVendor Laboratorni medicina AS - Key offerings; 12.4 GeneCopoeia Inc.; GeneCopoeia Inc. - Overview; GeneCopoeia Inc. - Product / Service; GeneCopoeia Inc. - Key offerings; 12.5 HEIM BIOTEK; HEIM BIOTEK - Overview; HEIM BIOTEK - Product / Service; HEIM BIOTEK - Key offerings; 12.6 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; 12.7 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 12.8 Miltenyi Biotec B.V. and Co. KG; Miltenyi Biotec B.V. and Co. KG - Overview; Miltenyi Biotec B.V. and Co. KG - Product / Service; Miltenyi Biotec B.V. and Co. KG - Key news; Miltenyi Biotec B.V. and Co. KG - Key offerings; 12.9 NanoString Technologies Inc.; NanoString Technologies Inc. - Overview; NanoString Technologies Inc. - Product / Service; NanoString Technologies Inc. - Key offerings; 12.10 New England Biolabs Inc.; New England Biolabs Inc. - Overview; New England Biolabs Inc. - Product / Service; New England Biolabs Inc. - Key offerings; 12.11 OriGene Technologies Inc.; OriGene Technologies Inc. - Overview; OriGene Technologies Inc. - Product / Service; OriGene Technologies Inc. - Key offerings; 12.12 Perkin Elmer Inc.; Perkin Elmer Inc. - Overview; Perkin Elmer Inc. - Business segments; Perkin Elmer Inc. - Key news; Perkin Elmer Inc. - Key offerings; Perkin Elmer Inc. - Segment focus; 12.13 QIAGEN NV; QIAGEN NV - Overview; QIAGEN NV - Product / Service; QIAGEN NV - Key news; QIAGEN NV - Key offerings; 12.14 Quantabio; Quantabio - Overview; Quantabio - Product / Service; Quantabio - Key offerings; 12.15 Regulus Therapeutics Inc.; Regulus Therapeutics Inc. - Overview; Regulus Therapeutics Inc. - Product / Service; Regulus Therapeutics Inc. - Key offerings; 12.16 Takara Bio Inc.; Takara Bio Inc. - Overview; Takara Bio Inc. - Product / Service; Takara Bio Inc. - Key news; Takara Bio Inc. - Key offerings; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global MicroRNA (MiRNA) Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Type - Market share 2023-2028 (%); Exhibits33: Data Table on Type - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Type; Exhibits35: Data Table on Comparison by Type; Exhibits36: Chart on Consumables - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Consumables - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Consumables - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Consumables - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Instruments - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Instruments - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Instruments - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Instruments - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Type ($ million); Exhibits45: Data Table on Market opportunity by Type ($ million); Exhibits46: Chart on End-user - Market share 2023-2028 (%); Exhibits47: Data Table on End-user - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by End-user; Exhibits49: Data Table on Comparison by End-user; Exhibits50: Chart on Academic and government research institutes - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Academic and government research institutes - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Academic and government research institutes - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Academic and government research institutes - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Biotechnology and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Biotechnology and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Biotechnology and pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Biotechnology and pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on CROs and clinical diagnostic centers - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on CROs and clinical diagnostic centers - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on CROs and clinical diagnostic centers - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on CROs and clinical diagnostic centers - Year-over-year growth 2023-2028 (%); Exhibits62: Market opportunity by End-user ($ million); Exhibits63: Data Table on Market opportunity by End-user ($ million); Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits67: Chart on Geographic comparison; Exhibits68: Data Table on Geographic comparison; Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits105: Market opportunity By Geographical Landscape ($ million); Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits107: Impact of drivers and challenges in 2023 and 2028; Exhibits108: Overview on criticality of inputs and factors of differentiation; Exhibits109: Overview on factors of disruption; Exhibits110: Impact of key risks on business; Exhibits111: Companies covered; Exhibits112: Matrix on companies position and classification; Exhibits113: BioVendor Laboratorni medicina AS - Overview; Exhibits114: BioVendor Laboratorni medicina AS - Product / Service; Exhibits115: BioVendor Laboratorni medicina AS - Key offerings; Exhibits116: GeneCopoeia Inc. - Overview; Exhibits117: GeneCopoeia Inc. - Product / Service; Exhibits118: GeneCopoeia Inc. - Key offerings; Exhibits119: HEIM BIOTEK - Overview; Exhibits120: HEIM BIOTEK - Product / Service; Exhibits121: HEIM BIOTEK - Key offerings; Exhibits122: Illumina Inc. - Overview; Exhibits123: Illumina Inc. - Business segments; Exhibits124: Illumina Inc. - Key news; Exhibits125: Illumina Inc. - Key offerings; Exhibits126: Illumina Inc. - Segment focus; Exhibits127: Merck KGaA - Overview; Exhibits128: Merck KGaA - Business segments; Exhibits129: Merck KGaA - Key news; Exhibits130: Merck KGaA - Key offerings; Exhibits131: Merck KGaA - Segment focus; Exhibits132: Miltenyi Biotec B.V. and Co. KG - Overview; Exhibits133: Miltenyi Biotec B.V. and Co. KG - Product / Service; Exhibits134: Miltenyi Biotec B.V. and Co. KG - Key news; Exhibits135: Miltenyi Biotec B.V. and Co. KG - Key offerings; Exhibits136: NanoString Technologies Inc. - Overview; Exhibits137: NanoString Technologies Inc. - Product / Service; Exhibits138: NanoString Technologies Inc. - Key offerings; Exhibits139: New England Biolabs Inc. - Overview; Exhibits140: New England Biolabs Inc. - Product / Service; Exhibits141: New England Biolabs Inc. - Key offerings; Exhibits142: OriGene Technologies Inc. - Overview; Exhibits143: OriGene Technologies Inc. - Product / Service; Exhibits144: OriGene Technologies Inc. - Key offerings; Exhibits145: Perkin Elmer Inc. - Overview; Exhibits146: Perkin Elmer Inc. - Business segments; Exhibits147: Perkin Elmer Inc. - Key news; Exhibits148: Perkin Elmer Inc. - Key offerings; Exhibits149: Perkin Elmer Inc. - Segment focus; Exhibits150: QIAGEN NV - Overview; Exhibits151: QIAGEN NV - Product / Service; Exhibits152: QIAGEN NV - Key news; Exhibits153: QIAGEN NV - Key offerings; Exhibits154: Quantabio - Overview; Exhibits155: Quantabio - Product / Service; Exhibits156: Quantabio - Key offerings; Exhibits157: Regulus Therapeutics Inc. - Overview; Exhibits158: Regulus Therapeutics Inc. - Product / Service; Exhibits159: Regulus Therapeutics Inc. - Key offerings; Exhibits160: Takara Bio Inc. - Overview; Exhibits161: Takara Bio Inc. - Product / Service; Exhibits162: Takara Bio Inc. - Key news; Exhibits163: Takara Bio Inc. - Key offerings; Exhibits164: Thermo Fisher Scientific Inc. - Overview; Exhibits165: Thermo Fisher Scientific Inc. - Business segments; Exhibits166: Thermo Fisher Scientific Inc. - Key news; Exhibits167: Thermo Fisher Scientific Inc. - Key offerings; Exhibits168: Thermo Fisher Scientific Inc. - Segment focus; Exhibits169: Inclusions checklist; Exhibits170: Exclusions checklist; Exhibits171: Currency conversion rates for US$; Exhibits172: Research methodology; Exhibits173: Information sources; Exhibits174: Data validation; Exhibits175: Validation techniques employed for market sizing; Exhibits176: Data synthesis; Exhibits177: 360 degree market analysis; Exhibits178: List of abbreviations